Nakornthon Hospital PCLBKK:NKT -1.57%19 EBITDA Margin % is 14.08% as of Mar. 2026, which is 39% below its 10-year median of 23.05. GuruFocus rates BKK:NKT with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Nakornthon Hospital PCL ranks better than 69.37% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nakornthon Hospital PCL EBITDA Margin % Related Terms
Nakornthon Hospital PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:NKT vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Nakornthon Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nakornthon Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nakornthon Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nakornthon Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nakornthon Hospital PCL (BKK:NKT) has a EBITDA Margin % of 14.08% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nakornthon Hospital PCL and its competitors. This is 39% below median its historical median of 23.05. Over the past decade, Nakornthon Hospital PCL's EBITDA Margin % has ranged from 18.08 to 26.11. According to the industry distribution chart, Nakornthon Hospital PCL ranks #204 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 30.6%.
Is Nakornthon Hospital PCL's EBITDA Margin % too high?
Nakornthon Hospital PCL's current EBITDA Margin % of 14.08% is 39% below median its 10-year median of 23.05. Over the past 10 years, this metric has ranged from a low of 18.08 to a high of 26.11. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Nakornthon Hospital PCL's value of 14.08% is 37.9% above this industry median. Based on the distribution chart, Nakornthon Hospital PCL ranks #204 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nakornthon Hospital PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Nakornthon Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nakornthon Hospital PCL ranks #204 out of 666 companies for EBITDA Margin %. This puts Nakornthon Hospital PCL in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Nakornthon Hospital PCL's value of 14.08% is 37.9% above this benchmark. Historically, Nakornthon Hospital PCL's own EBITDA Margin % has ranged from 18.08 to 26.11 over the past decade. While the company's 10-year median is 23.05 vs. the industry median of 10.21, Nakornthon Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nakornthon Hospital PCL's current EBITDA Margin % of 14.08% is 37.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nakornthon Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nakornthon Hospital PCL's current EBITDA Margin % is 14.08%, which is 39% below median its own 10-year median of 23.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakornthon Hospital PCL stock overvalued right now?
Nakornthon Hospital PCL (BKK:NKT) has a current EBITDA Margin % of 14.08%. The current EBITDA Margin % is 14.08%, which is 39% below median its 10-year median of 23.05 and 37.9% above the Healthcare Providers & Services industry median of 10.21. Nakornthon Hospital PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nakornthon Hospital PCL (BKK:NKT), the current EBITDA Margin % is 14.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nakornthon Hospital PCL is engaged in the healthcare industry. It is principally engaged in the hospital business offering specialty centers such as Orthopedics Center, Neurology Center, Gastrointestinal and Liver Center, and Nakornthon Fertility Center by Superior A.R.T. The company has two reportable segments which are hospital operations and other businesses that support hospital business including distribution of health and cosmetic products, facility management, and restaurant. A majority of its revenue is generated from the hospital business. Its operations are carried on in the geographical area of Thailand.
19GF Score
Get the complete analysis for BKK:NKT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NKT has been successfully added to your 
